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Abstract
Background
Uncertainty remains about the true extent by which alcohol consumption causes a number
of health outcomes. Genetic variants, or combinations of variants built into a polygenic risk
score (PGRS), can be used in an instrumental variable framework to assess causality
between a phenotype and disease outcome of interest, a method known as Mendelian ran-
domisation (MR). We aimed to identify genetic variants involved in the aetiology of alcohol
consumption, and develop a PGRS for alcohol.
Methods
Repeated measures of alcohol consumption from mothers and their offspring were collected
as part of the Avon Longitudinal Study of Parents and Children. We tested the association
between 89 SNPs (identified from either published GWAS data or from functional literature)
and repeated measures of alcohol consumption, separately in mothers (from ages 28–48)
and offspring (from ages 15–21) who had ever reported drinking. We modelled log units of
alcohol using a linear mixed model and calculated beta coefficients for each SNP sepa-
rately. Cross-validation was used to determine an allelic score for alcohol consumption, and
the AVENGEME algorithm employed to estimate variance of the trait explained.
Results
Following correction for multiple testing, one SNP (rs1229984) showed evidence for associ-
ation with alcohol consumption (β = -0.177, SE = 0.042, p = <0.0001) in the mothers. No
SNPs showed evidence for association in the offspring after correcting for multiple testing.
The optimal allelic score was generated using p-value cut offs of 0.5 and 0.05 for the moth-
ers and offspring respectively. These scores explained 0.3% and 0.7% of the variance.
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Conclusion
Our PGRS explains a modest amount of the variance in alcohol consumption and larger
sample sizes would be required to use our PGRS in an MR framework.
Introduction
Alcohol is a leading preventable cause of ill health in Europe [1], with Europeans accounting
for more than a quarter of the total worldwide alcohol consumption (despite making up 15%
of the global population) [2]. Despite this, uncertainty remains about the true extent by which
alcohol consumption in the general population causes a number of health outcomes including
type 2 diabetes [3] and cardiovascular disease [4] mainly because of bias in conventional epide-
miological studies.
Genetic variants can be used in an instrumental variable framework to improve evidence
on causality between an exposure and disease outcome of interest, a method known as Mende-
lian randomisation (MR) [5]. Details of the rationale and assumptions of MR have been dis-
cussed in detail elsewhere [6]. In brief, the allocation of genetic variants is random at
conception, therefore the frequency of those variants associated with an exposure of interest
should be approximately the same in groups of individuals with different confounding factors.
Furthermore, as genotype is determined at conception, it cannot be susceptible to reverse cau-
sation [5, 7], which is particularly problematic when studying long-term effects of alcohol use
(“sick-quitter effect” [3, 8]). Holmes et al (2014) [9] used rs1229984 (a genetic variant in
ADH1B) in an MR framework to examine the causal impact of alcohol on cardiovascular dis-
ease in European populations while other examples can be found in East Asian populations
[10–12]. Polygenic risk scores (PGRS) can also be used in an MR framework, accounting for a
greater proportion of the variance in the exposure phenotype of interest, thus increasing
power. Use of PGRS in MR can avoid or alleviate weak instrument bias [13], which is a com-
mon problem in MR. Furthermore, in the instance that researchers wish to use a PGRS in a
large cohort that has genotyping availability but no GWAS data, a finite number of SNPs from
the PGRS can be easily and cost effectively genotyped for that purpose.
There are clear advantages of using PGRS in MR studies of alcohol consumption, however
to date there are no known variants robustly associated with alcohol drinking in populations
of European origin, other than the relatively rare ADH1B used by Holmes et al [9]. This is
despite estimates of heritability for alcohol use disorders and consumption reaching approxi-
mately 50% at their peak [14–17], and linkage and genome wide association studies (GWAS)
suggesting a variety of potential loci that might be implicated [18–20]. The majority of GWAS
for alcohol phenotypes focus on dependence rather than heaviness of use [21–24], and among
the top findings are often alcohol dehydrogenase genes (ADH) and aldehyde dehydrogenase
(ALDH2) [25–27], which have also been reported in candidate gene studies of metabolic reac-
tions following ingestion [28].
We therefore aimed to identify genetic variants likely to play a role in the aetiology of alco-
hol consumption. Our end goal was to develop a polygenic risk score for average alcohol con-
sumption in the general population, which could be specific to consumption and explain a
larger proportion of the variance than the known ADH1B variant. We used a multi-step
approach, by [a] Identifying genetic variants that could plausibly be associated with alcohol
consumption from genome wide association studies (GWAS) and the functional literature, [b]
Estimating their association with alcohol consumption in mothers (heritability is estimated to
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be higher after college years) and offspring from the Avon Longitudinal Study of Parents and
Children (ALSPAC), and [c] Creating PGRSs (based on the initial set of SNPs) and estimating
the proportion of variance explained for both mothers and offspring’s phenotypes. We fitted
both cross-sectional and longitudinal models, thus taking advantage of the repeated measures
of alcohol consumption available at different time points in life to minimise noise in the defini-
tion/reporting of alcohol use.
Methods
Study Population
Data were taken from the Avon Longitudinal Study of Parents and Children (ALSPAC), a lon-
gitudinal study situated in South West England. ALSPAC recruited 14,541 pregnant women
between 1991 and 1992, with over 14,062 live births resulting from these pregnancies. Com-
parison with the 1991 census shows the sample was broadly representative of the British popu-
lation [29]. Both mothers and offspring have been followed up with a series of questionnaires,
clinics and lab-based assessments over the past 25 years, which has allowed for a wide range of
phenotypic and biological measures to be collected. Ethical approval was obtained from the
ALSPAC Ethics and Law Committee and the Local Research Ethics Committees. Further
information of the recruitment process is available elsewhere [29–31]. The study website con-
tains details of all data through a searchable data dictionary [32].
We used data from 10 postal questionnaires completed by the mothers in the cohort over
18 years (ranging from a mean age of 28 at baseline to a mean age of 48 at 18 years post preg-
nancy) and questionnaires completed by ALSPAC offspring over 6 years (ranging from age 15
to 21 years). All individuals who had available genetic data (outlined below) and answered
alcohol related questions at these time points were included in the analysis (Mother N = 1609
to 3912; Offspring N = 2604 to 7989, Table 1).
Phenotypic Measures
Weekly alcohol consumption (units). In all alcohol related questions used in this
research, participants were informed that “one drink referred to½ pint of beer/cider, a small
(125ml) glass of wine or a single (25ml) measure of spirit”, with each of these drinks containing
approximately one UK unit of alcohol. Weekly alcohol consumption was treated as a continu-
ous measure of UK units.
Mothers’ weekly alcohol consumption between zero and three years post pregnancy and at
six years post pregnancy were calculated using the question “How often have you drunk alco-
holic drinks”. Participants selected one of the following responses: “Never”; “Less than 1 glass a
week”; “At least 1 glass a week”; “1–2 glasses every day”; “At least 1–9 glasses every day”; “At least
10 glasses every day”. At zero years post pregnancy, this question related to the amount of alco-
hol consumed before the current pregnancy. At four years post pregnancy and between seven
and 12 years post pregnancy, weekly alcohol consumption was calculated from self-reported
beers/ciders, wines, spirits, other alcohol or low alcohol beverages consumed on each day of
the previous week. Weekly alcohol consumption at 18 years post pregnancy was calculated by
multiplying the number of days the mother generally drank by the number of drinks con-
sumed on a typical drinking data (S1 Table).
Offspring’s weekly alcohol consumption between ages 15 and 21 years was calculated by
multiplying the frequency at which the child drank by the number of drinks consumed on a
normal drinking day (S2 Table).
Potential covariates. Mothers’ covariates included: Cigarettes per day treated as a contin-
uous measure at one, two, three and six years post pregnancy; age in years; social class (III
Alcohol Consumption Polygenic Risk Score
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manual skilled, IV and V unskilled manual or casual workers or those who rely on state for
their income/I and II professional occupations and managerial and technical occupations and
III non-manual skilled workers); highest level of education (certificate of secondary education/
vocational qualification/O level/A level/Degree); cannabis, antidepressant, amphetamine and
opiate use in the past year (No/Yes) at one, two, three and six years post pregnancy.
Offspring’s covariates included: Sex; ethnicity (white/other); DSM-IV classification of anxi-
ety, depression, conduct disorder and ADHD at ages 7, 10, 13 and 15 years; Binge eating in the
past year at ages 13, 14, 16 and 18 years; antisocial behaviour at ages 11, 13, 14, 15, 18, 19 and
21 years (all coded No/Yes); and mothers highest level of education (certificate of secondary
education/vocational qualification/O level/A level/Degree).
Genetic Measures
ALSPAC offspring were genotyped using the Illumina HumanHap550 quad chip genotyping
platforms by 23andMe subcontracting the Wellcome Trust Sanger Institute, Cambridge, UK
and the Laboratory Corporation of America, Burlington, NC, US. ALSPAC mothers were gen-
otyped using the Illumina human660W-quad array at Centre National de Ge´notypage (CNG).
Following quality control (individual call rate> 0.97, SNP call rate>0.95, MAF > 0.01,
HWE > 1E-7, cryptic relatedness within mothers and within offspring IBD< 0.1, non-Euro-
pean clustering individuals removed) 9237 offspring and 8196 mothers were retained with
477482 SNP genotypes in common between them. SNPs were flipped to forward strand and
Table 1. Summary information of weekly alcohol consumption across all time points.
Timepoint Alcohol units per week
N Mean units (SD) Median units (IQR) Zeros (%) Mean age (SD)
Child 1
15 years (C) 3912 2.5 (6.4) 0.5 (0–2) 39 15.1 (0.3)
16 years (Q) 3573 9.6 (10.9) 4.5 (0.38–16.5) 9 16.2 (0.4)
17 years (C) 3059 10.1 (9.9) 7.5 (1.38–16.5) 5 17.2 (0.4)
18 years (Q) 2427 13.3 (11.8) 8.25 (3.75–24) 6 18.2 (0.6)
21 years (Q) 2973 8.4 (9.6) 6 (2–8.75) 4 20.5 (0.5)
All child 17998 8.3 (10.3) 4.1 (0.6–13.8) 13 16.7 (2.3)
Mother 2
Baseline 7425 3.6 (6.1) 3.5 (0.5–3.5) 7 28.2 (4.8)
1 years (Q) 6641 1.6 (3.3) 0.5 (0.5–1.5) 11 29.5 (4.7)
2 years (Q) 6224 2.5 (4.4) 0.5 (0.5–3.5) 13 30.7 (4.6)
3 years (Q) 5952 2.8 (4.7) 0.5 (0.5–3.5) 11 32.9 (4.5)
4 years (Q) 7989 3.6 (5.6) 1.0 (0–6) 47 34.0 (4.5)
6 years (Q) 5601 3.8 (6.1) 3.5 (0.5–3.5) 8 34.2 (4.5)
7 years (Q) 7973 4.3 (8.4) 0 (0–6) 52 36.3 (4.5)
8 years (Q) 7962 4.1 (8.7) 0 (0–6) 52 37.5 (4.4)
12 years (Q) 4379 6.5 (6.9) 5 (1–9) 19 41.5 (4.4)
18 years (Q) 2604 6.0 (6.5) 3.8 (1.1–8.3) 0 48.3 (4.3)
All mother 67988 3.7 (6.5) 1.1 (0–4) 24 34.0 (6.8)
1 All offspring’s time points represent the age at which the questionnaire/clinic was administered.
2 All mothers time points correspond to the amount of time since the end of the first pregnancy (i.e. pregnancy enrolled into ALSPAC); baseline corresponds
to a questionnaire administered at enrolment into the study that reflects alcohol use before pregnancy.
(C) = data collected during a clinic session; (Q) data collected using a postal questionnaire.
doi:10.1371/journal.pone.0167360.t001
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haplotypes were estimated on the combined sample using ShapeIT (v2.r644). Imputation was
performed using Impute V2.2.2 against all 2186 reference haplotypes (including non-Europe-
ans) in the December 2013 release of the 1000 genomes reference haplotypes (Version 1 Phase
3). This gave 8237 eligible offspring and 8196 eligible mothers with available genotype data.
To identify SNPs with some a priori evidence of association with alcohol consumption/
potentially associated with alcohol consumption, we searched the NHGRI-EBI GWAS cata-
logue [33] for published GWAS of alcohol-related phenotypes, using the following search
terms: “Alcohol consumption”; “Alcohol dependence”; and “Alcoholism”. 68 SNPs were asso-
ciated with at least one of the latter phenotypes at a P value < 1.0 x 10−5. We supplemented
this list with a search for candidate gene or functional studies of alcohol consumption, identi-
fying a further 23 SNPs, bringing the total number of SNPs to 91 (note that three SNPs were
identified from functional studies that had already been identified by the GWAS search). We
then extracted genotype data for the 91 SNPs from ALSPAC. 31 SNPs were directly genotyped.
For the remaining 60 SNPs, imputed genotypes with imputation r2>0.8 were available (two
SNPs with imputation r2<0.8 were excluded). 89 SNPs were therefore included in the analy-
ses. A full summary of selected SNPs is provided in S3 Table.
Statistical Analysis
All analyses were conducted using Stata13 [34]. We tested for association between weekly alco-
hol consumption and the 89 SNPs in both mothers and offspring separately. For alcohol con-
sumption, an abundance of zeros was expected, since no consumption would be reported both
by those offspring and mothers who never drink, and by offspring and mothers who had not
drank in the preceding week. To analyse cross-sectional and repeated measures of these data
we log-transformed units and focussed analysis only on those who had ever reported drinking
(i.e. dropping non-drinkers). We modelled log units using a linear mixed model and calculated
the beta coefficient of each SNP as a function of the number of copies of the minor allele. The
outcome was also assessed cross-sectionally using a log-linear regression at each time point
separately. In each model, we adjusted for age and controlled for population stratification
using the first 10 principal components. To test for pleiotropic effects, we examined the associ-
ations between the 89 SNPs and 48 potential confounders detailed above.
We used the Bonferroni method to correct for multiple testing. Evidence for association
was taken at p = 0.00056 (0.05/89) for repeated measures analyses and p = 0.000037 (0.05/
number of time points89) for the cross sectional analyses.
To determine a PGRS for alcohol consumption, we randomly separated the individuals into
80% training and 20% discovery sets. Repeated measures of log units were modelled in the
training set, separately for each of the 89 SNPs with beta coefficients, their standard error and
corresponding p-values recorded. Using p-value thresholds of 0.01, 0.05, 0.1, 0.2, 0.4 and 0.5
for inclusion, we then created a weighted PGRS for each threshold. These scores were used to
predict repeated measures of log-units in the 20% discovery set, with R-squared recorded for
the score corresponding to each p-value threshold. The process was repeated five times, and
the p-value threshold with the highest R-squared was taken as optimal. This was done inde-
pendently for mothers and offspring data. Finally, the AVENGEME [35] algorithm was
employed to estimate variance of the trait (i.e. alcohol units consumed in a week) explained by
the PGRSs.
To demonstrate a possible use of the PGRS, we tested the association between our PGRS on
proxy measures for cardiovascular disease [9] which were available both in mothers and in
their offspring, namely HDL cholesterol, systolic blood pressure and diastolic blood pressure.
These were modelled against the two PGRS while controlling for age at measurement.
Alcohol Consumption Polygenic Risk Score
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Sensitivity Analysis
The above statistical methods were used to conduct the following sensitivity analyses using the
mother’s data: (a) excluding individuals who were pregnant at completion of the question-
naire; and (b) excluding weekly alcohol consumption measures at four, seven, eight and 12
years post pregnancy in the mothers as these questions were phrased differently from the other
time points (S1 Table).
Results
ALSPAC Mothers
For the ALSPAC mothers, there were 67988 questionnaire responses to units consumed,
between the ages of 28 to 48 years. Alcohol consumption increased over the course of the ques-
tionnaires and over age (Table 1).
In the repeated measures analysis, six SNPs had a p value < 0.05. Following correction for
multiple testing, one SNP (rs1229984) showed evidence for association with alcohol consump-
tion (β = -0.177, SE = 0.042, p = 0.00002) (Table 2 and S4 Table). In the cross sectional analy-
ses, 27 SNPs had a p value < 0.05 at a minimum of one time point. The top ranked SNP was
rs1229984 with the alcohol consumption variable measured at 12 years post pregnancy (differ-
ence in units per week for each additional copy of the minor allele = -0.326, SE = 0.084,
P = 0.0001). This SNP also showed evidence for association (multiple testing threshold) at
baseline (difference in units per week for each additional copy of the minor allele = -0.19,
SE = 0.051, P = 0.0002) and was consistently negatively associated with alcohol consumption
across all time points (Fig 1). (S5 Table). None of the mother’s covariates showed evidence for
association with any of individual SNPs following correction for multiple testing (S6 Table).
ALSPAC Offspring
Units of alcohol consumed were measured 17998 times over 5 questionnaires during adoles-
cence for the ALSPAC offspring, from age 15 to 20.5. The average number of units peaked at
13 per week at age 18 years, dropping to 8 per week by age 21 years (Table 1).
In the repeated measures analysis, six SNPs had a p value < 0.05. Following correction for
multiple testing, no SNPs showed evidence for association (Table 2 and S4 Table). In cross sec-
tional analyses, 28 SNPs had a p value < 0.05 at a minimum of one time point. The top ranked
SNP in the offspring was rs2228093 with the alcohol consumption variable measures at age 18
years (difference in units per week for each additional copy of the minor allele = -0.105,
SE = 0.036, P = 0.004), however this did not meet the p value threshold for multiple testing (S5
Table). In contrast to the ALSPAC mothers, rs1229984 did not pass multiple testing thresholds
for alcohol consumption in repeated measures analysis and did not show a consistent pattern
across all time points tested (Fig 1). None of the offspring’s covariates showed evidence for
association with any of individual SNPs following correction for multiple testing (S6 Table).
Sensitivity Analysis
When excluding non-pregnant women and data from questionnaires at four, seven, eight and
12 years post pregnancy, rs1229984 remained the only SNP associated with weekly alcohol
consumption (excluding pregnant women: increase in units per week for each additional copy
of the minor allele = -0.159, SE = 0.042, P = 0.0001; excluding questionnaires: increase in units
per week for each additional copy of the minor allele = -0.149, SE = 0.039, P = 0.0001) (S7
Table).
Alcohol Consumption Polygenic Risk Score
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Polygenic Risk Score
The best allelic score was generated using p value cut offs of 0.5 and 0.05 for the mothers and
offspring, respectively, which resulted in including a total of 42 SNPs (out of 89) for mothers
and 6 SNPs (out of 89) for offspring. For the ALSPAC mothers, the variance in units of alcohol
per week explained was 0.3% (95% CI 0.13% to 0.76%). For the ALSPAC offspring the variance
explained was 0.66% (95% CI 0.22% to 1.3%). Neither of the PGRS showed evidence for associ-
ation with any of the confounders, i.e. there was no evidence to suggest that the PGRS could be
violating the second assumption of instrumental variables (that the instrument is independent
of the confounders of the original exposure-outcome association) and therefore being invalid
as an instrumental variable to proxy for alcohol intake (S6 Table).
When modelling the effect of our PGRS on cardiovascular disease risk factors, there was
evidence for association between the offspring PGRS and offspring diastolic blood pressure in
the expected direction (beta = 1.61, 95% CI 0.25 to 2.97, p = 0.020). However, our estimates of
the association between the offspring PGRS and both HDL cholesterol and systolic blood pres-
sure provided no strong evidence of association (HDL cholesterol: beta = 0.06, 95% CI -0.03 to
0.14, p = 0.177; systolic blood pressure: beta = 1.44, 95% CI -0.84 to 3.72, p = 0.216). Similarly,
there was no statistical evidence for association between the mothers PGRS and any of the
Fig 1. Association between rs1229984 and alcohol consumption over time.
doi:10.1371/journal.pone.0167360.g001
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cardiovascular disease risk factors (HDL cholesterol beta = 0.39, 95% CI -0.10 to 0.17, p =
0.565; systolic blood pressure beta = -0.68, 95% CI -7.05 to 5.69, p = 0.0.835; diastolic blood
pressure beta = 2.14, 95% CI -2.34 to 6.62, p = 0.350).
Discussion
The aim of this study was to develop a polygenic risk score for alcohol consumption, in view of
using this to assess the causal impact of alcohol on health related outcomes such as cardiovas-
cular disease. Literature searches of published GWAS and functional studies identified 89 can-
didate SNPs that had previously shown some evidence of association with alcohol-related
phenotypes. Using repeated measures analysis of alcohol behaviour over the course of a 20
year period, we found strong evidence confirming that rs1229984 plays a role in alcohol con-
sumption, confirming previous results [9]. This SNP was associated with a decrease of 0.84
units of alcohol per week, on average. It was found to be associated in cross-sectional analyses
of questionnaires measured 20 years apart and effect estimates were stronger in the repeated
measures analysis, strengthening the evidence that it relates to alcohol consumption through-
out the life course. The PGRS derived through cross-validation only explained a modest pro-
portion of the variance in alcohol consumption (0.3% for mothers and 0.66% for the offspring
in our sample).
The score could in principle be used to conduct MR analyses for example in the field of car-
diovascular disease (CVD), although large sample sizes would be required. The British Heart
Foundation estimates that there are 7m people living with CVD in the UK (~10% of the popu-
lation) [36], if the odds ratio for alcohol consumption on CVD incidence was 0.75 (OR for
CVD mortality used) [37], we would require a sample size of 126,500 (assuming a 1:1 ratio,
80% power, alpha = 0.05 and R2 = 0.3% from the mothers PGRS result), or 54,200 (assuming a
1:1 ratio, 80% power, alpha = 0.05 and R2 = 0.7% from the offspring’s PGRS result)[38]. Simi-
larly, the incidence odds ratio for coronary heart disease (CHD) is 0.71 [37], with 2.3 million
in the UK living with CHD. To perform an MR analysis to examine the effect of alcohol con-
sumption on CHD using the mothers PGRS we would need 89,300 with 38,300 individuals
needed for the offspring’s PGRS. The required sample sizes are much larger than those in our
sample, therefore our tests of association between the PGRSs and proxy measures of cardiovas-
cular disease are underpowered. As such, we cannot be certain that the lack of associations are
representative of null results.
Strengths and limitations
ALSPAC is a well characterised birth cohort with repeated measures of alcohol use, which
have been used in several other studies of substance use [39–41]. Moreover, the available data
were collected on mothers and their offspring over the course of 20 years. As such, they are an
excellent resource to investigate alcohol behaviour over time. The nature of this
dataset allowed for the use of repeated measures to strengthen the phenotype. Furthermore,
the wealth of additional data allowed for detailed sensitivity analyses and examining of a wide
range of potential covariates to test for pleiotropic effects of the alcohol variants and the
derived PGRSs. An additional strength comes from the way our PGRS was constructed. By
taking a limited number of SNPs that have previously shown some evidence of association
with alcohol behaviours (either from GWAS or functional literature) we have developed a
PGRS that has a reduced number of SNPs compared to the numbers that might be required if
using p value cut offs from whole GWAS. The advantage to this approach is that the resulting
PGRS is less likely to have pleiotropic effects than one from a deep GWAS list. Furthermore,
Alcohol Consumption Polygenic Risk Score
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this finite number of SNPs would therefore be more cost effective to genotype and could,
therefore, be feasibly used in a study that does not have access to genome wide data.
There are also some limitations which need to be considered when interpreting the results
of this study. First, the set of SNPs identified through searches came from GWAS analyses of
alcohol dependence [21–24] and so might not show an association with our phenotype (units
of alcohol per week). Meanwhile, functional literature reports the role of genetic variants in
metabolism, however the effects of these genes are not taken as far as alcohol consumption.
Second, alcohol consumption questions were not uniform over time, however sensitivity anal-
yses excluding data from a different version of the questionnaire returned similar results.
Third, our data on alcohol consumption are based on self-report and so may be subject to mis-
classification. However, there are currently no reliable biological alternatives for alcohol use in
a general population sample [42], with current biomarkers only being able to identify long
term heavy use [43, 44]. One might expect to find that the direction of bias differs in the two
populations of mothers and offspring, as mothers might underreport their use (negatively
impacting estimates), while offspring might over-report their consumption (positively impact-
ing estimates) [45–47]. Fourth, there was loss to follow up, with greater proportions of missing
data in later questionnaires, which reduced statistical power and could lead to selection bias if
alcohol consumption is related to the loss to follow up. This drop in sample size also meant
that stratifying the offspring analysis by gender would reduce the power, however we did
adjust for gender in this analysis. Furthermore, we were unable to examine the association
between SNPs and alcohol consumption in adult males (i.e. fathers) as their genetic data was
not available. Finally, we found no suitable independent cohort study with life course alcohol
consumption data for testing PGRS performance and hence we used cross-validation in
ALSPAC. However, it has previously been reported that sample sizes such as those used in this
analysis are adequate when using two separate ‘training’ and ‘testing’ samples [48].
Findings in relation to other research
Burgess and colleagues suggested that variants with known biology are better for use in MR
studies [49]. The underlying biology of some of the SNPs (those selected from functional litera-
ture) included in our analysis is known, and linked to changes in alcohol metabolism, and as
such, would be better for use in a PGRS MR analysis. One SNP (rs1229984 in ADH1B) was
consistently identified as being associated with alcohol consumption in ALSPAC mothers.
This SNP has previously been used in an MR framework, after Holmes and colleagues vali-
dated it as a genetic instrument by providing solid evidence for association with various alco-
hol phenotypes (including units of alcohol per week) in a sample of>200,000 participants [9].
In their estimate, carriers of the minor allele consumed 17.2% fewer units per week than non-
carriers, which is very similar to our result of 0.177 fewer log units per week (equivalent to
16.2% fewer units per week).
The set of SNPs included in the mothers PGRS and offspring PGRS were different, possibly
due to age and gender effects. Previous literature has suggested that the heritability of alcohol
consumption changes across the life course. Estimates start to increase at the age of 15 years
and peak in the mid-20’s [14–17]. It is therefore possible that the offspring are so young that
their genetic potential to abuse or avoid alcohol is not yet fully expressed. Conversely, the age
of the ALSPAC mothers at baseline ranged from 14 to 46 years (mean = 28 years), with these
individuals being followed up for 20 years. Since the mothers’ longitudinal analyses cover a
wide range of ages across the life course, it is not possible to make assumptions about the
impact of age on the PGRS composition or the proportion of the variance it explains, in rela-
tion to the offspring’s PGRS. Additionally, gender differences may also have a role if there are
Alcohol Consumption Polygenic Risk Score
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systematic differences in alcohol consumption by gender. However, stratifying by gender here
would reduce power in the analysis.
PGRS have previously been used in an MR framework to evaluate the causal effect of a
number of traits/exposures, with proportions of the variance explained in the trait in the range
or 1.5–3% (e.g. BMI: 1.5% - 2.5% [50–52], type 2 diabetes: ~2% [53], schizophrenia: ~3% [54]).
However, the proportion of the variance explained by our PGRS is comparable to the variance
of age of onset of alcohol consumption explained by a previously reported PGRS [55]. In our
analysis, the variation explained by the initial 89 SNPs selected was estimated to be between
0.13% and 0.76% for the ALSPAC mothers. A previous PGRS for tobacco (cigarettes smoked
per day) was shown to explain 0.4–0.5% of the variance in glasses of alcohol per week [56],
which is comparable in magnitude to the variance explained by our PGRS for alcohol con-
sumption. This provides additional evidence that some genetic risk factors are shared between
substances, suggesting that incorrect effect estimates could be introduced through pleiotropy.
However, the lack of evidence for association between our PGRSs and potential confounders
(including tobacco and other drug use) suggesting minimal evidence for pleiotropy. These
comparisons are limited by design differences (i.e. genome wide analysis in previous literature
compared to the candidate gene approach here). However, in theory, our selection process
identified ‘a-priori’ candidates and we would therefore expect a higher proportion of the vari-
ance to be explained in this analysis. This highlights how little we know about the genetic con-
tribution to alcohol consumption.
Conclusion
The PGRSs developed in our analyses explained a modest proportion of the variance in alcohol
consumption for both ALSPAC mothers and offspring. For future MR analyses examining the
causal effects of drinking alcohol in the general population, the mothers’ PGRS reported here
is most likely a more suitable genetic proxy as it is based on a breadth of ages, although one
limitation to this discovery sample is the inclusion of women only. Very large sample sizes,
such as those from multi-study consortia, would be required if these PGRSs were to be used as
genetic instruments in MR analyses.
Supporting Information
S1 Table. Mothers questionnaire information–Alcohol consumption.
(DOCX)
S2 Table. Offspring questionnaire information–Alcohol consumption.
(DOCX)
S3 Table. SNP Information.
(DOCX)
S4 Table. All results for repeated measures alcohol consumption in ALSPAC mothers and
offspring.
(DOCX)
S5 Table. All results for cross sectional alcohol consumption, mothers (time points M0 to
M18) and offspring (times points C15 to C21).
(DOCX)
S6 Table. Associations between PGRS, individual SNPs and potential confounders (Bon-
ferroni corrected p-value = 0.00011).
(DOCX)
Alcohol Consumption Polygenic Risk Score
PLOS ONE | DOI:10.1371/journal.pone.0167360 November 30, 2016 11 / 15
S7 Table. Sensitivity analysis for repeated measures analysis in ALSPAC mothers.
(DOCX)
Acknowledgments
We are extremely grateful to all the families who took part in this study, the midwives for their
help in recruiting them, and the whole ALSPAC team, which includes interviewers, computer
and laboratory technicians, clerical workers, research scientists, volunteers, managers, recep-
tionists and nurses. The UK Medical Research Council and the Wellcome Trust and the Uni-
versity of Bristol provide core support for ALSPAC. This publication is the work of the authors
and all authors will serve as guarantors for the contents of this paper. GWAS data was gener-
ated by Sample Logistics and Genotyping Facilities at the Wellcome Trust Sanger Institute and
LabCorp (Laboratory Corporation of American using support from 23andMe.
Author Contributions
Conceptualization: LZ PH.
Data curation: MT AS.
Formal analysis: AS MT FD.
Investigation: AS MT FD.
Methodology: AS MT FD.
Project administration: LZ.
Resources: MT LZ PC AS FD.
Supervision: LZ.
Validation: MT LZ PC FD AS.
Visualization: AS MT.
Writing – original draft: MT.
Writing – review & editing: MT AS LZ FD PC.
References
1. Rehm J, Shield K, Rehm M, Gmel G, Frick U. Alcohol consumption, alcohol dependence and attribut-
able burden of disease in Europe. Centre for Addiction and Mental Health. 2012.
2. Organization WH. Global status report on alcohol and health, 2014. 2014.
3. Koppes LL, Dekker JM, Hendriks HF, Bouter LM, Heine RJ. Moderate Alcohol Consumption Lowers the
Risk of Type 2 Diabetes A meta-analysis of prospective observational studies. Diabetes care. 2005; 28
(3):719–25. PMID: 15735217
4. Glymour M. Alcohol and cardiovascular disease. Bmj. 2014; 349:g4334. doi: 10.1136/bmj.g4334 PMID:
25011451
5. Lawlor DA, Harbord RM, Sterne JA, Timpson N, Davey Smith G. Mendelian randomization: using
genes as instruments for making causal inferences in epidemiology. Statistics in medicine. 2008; 27
(8):1133–63. doi: 10.1002/sim.3034 PMID: 17886233
6. Smith GD, Hemani G. Mendelian randomization: genetic anchors for causal inference in epidemiologi-
cal studies. Human molecular genetics. 2014; 23(R1):R89–R98. doi: 10.1093/hmg/ddu328 PMID:
25064373
7. Smith GD, Lawlor DA, Harbord R, Timpson N, Day I, Ebrahim S. Clustered environments and random-
ized genes: a fundamental distinction between conventional and genetic epidemiology. PLoS medicine.
Alcohol Consumption Polygenic Risk Score
PLOS ONE | DOI:10.1371/journal.pone.0167360 November 30, 2016 12 / 15
2007; 4(12):e352. PubMed Central PMCID: PMC2121108. doi: 10.1371/journal.pmed.0040352 PMID:
18076282
8. Rehm J, Irving H, Ye Y, Kerr WC, Bond J, Greenfield TK. Are lifetime abstainers the best control group
in alcohol epidemiology? On the stability and validity of reported lifetime abstention. American journal of
epidemiology. 2008; 168(8):866–71. doi: 10.1093/aje/kwn093 PMID: 18701442
9. Holmes MV, Dale CE, Zuccolo L, Silverwood RJ, Guo Y, Ye Z, et al. Association between alcohol and
cardiovascular disease: Mendelian randomisation analysis based on individual participant data. Bmj.
2014; 349:g4164. doi: 10.1136/bmj.g4164 PMID: 25011450
10. Irons DE, McGue M, Iacono WG, Oetting WS. Mendelian randomization: a novel test of the gateway
hypothesis and models of gene-environment interplay. Development and psychopathology. 2007; 19
(4):1181–95. doi: 10.1017/S0954579407000612 PMID: 17931442
11. Yeung SLA, Jiang C, Cheng KK, Liu B, Zhang W, Lam TH, et al. Is aldehyde dehydrogenase 2 a credi-
ble genetic instrument for alcohol use in Mendelian randomization analysis in Southern Chinese men?
International journal of epidemiology. 2013; 42(1):318–28. doi: 10.1093/ije/dys221 PMID: 23243119
12. Taylor AE, Lu F, Carslake D, Hu Z, Qian Y, Liu S, et al. Exploring causal associations of alcohol with car-
diovascular and metabolic risk factors in a Chinese population using Mendelian randomization analysis.
Scientific reports. 2015; 5.
13. Burgess S, Thompson SG. Use of allele scores as instrumental variables for Mendelian randomization.
International journal of epidemiology. 2013; 42(4):1134–44. doi: 10.1093/ije/dyt093 PMID: 24062299
14. Bevilacqua L, Goldman D. Genes and addictions. Clinical pharmacology and therapeutics. 2009; 85
(4):359. doi: 10.1038/clpt.2009.6 PMID: 19295534
15. Verhulst B, Neale M, Kendler K. The heritability of alcohol use disorders: a meta-analysis of twin and
adoption studies. Psychological medicine. 2015; 45(05):1061–72.
16. Bergen SE, Gardner CO, Kendler KS. Age-related changes in heritability of behavioral phenotypes over
adolescence and young adulthood: a meta-analysis. Twin Research and Human Genetics. 2007; 10
(03):423–33.
17. Swan GE, Carmelli D, Rosenman RH, Fabsitz RR, Christian JC. Smoking and alcohol consumption in
adult male twins: genetic heritability and shared environmental influences. J Subst Abuse. 1990; 2
(1):39–50. PMID: 2136102
18. Li MD, Burmeister M. New insights into the genetics of addiction. Nature Reviews Genetics. 2009; 10
(4):225–31. doi: 10.1038/nrg2536 PMID: 19238175
19. Edenberg HJ. The genetics of alcohol metabolism: role of alcohol dehydrogenase and aldehyde dehy-
drogenase variants. Alcohol Research & Health. 2007; 30(1):5–14.
20. Prescott C, Sullivan P, Kuo P, Webb B, Vittum J, Patterson De, et al. Genomewide linkage study in the
Irish affected sib pair study of alcohol dependence: evidence for a susceptibility region for symptoms of
alcohol dependence on chromosome 4. Molecular psychiatry. 2006; 11(6):603–11. doi: 10.1038/sj.mp.
4001811 PMID: 16534506
21. Gelernter J, Kranzler H, Sherva R, Almasy L, Koesterer R, Smith A, et al. Genome-wide association
study of alcohol dependence: significant findings in African-and European-Americans including novel
risk loci. Molecular psychiatry. 2014; 19(1):41–9. doi: 10.1038/mp.2013.145 PMID: 24166409
22. Bierut LJ, Agrawal A, Bucholz KK, Doheny KF, Laurie C, Pugh E, et al. A genome-wide association
study of alcohol dependence. Proceedings of the National Academy of Sciences. 2010; 107(11):5082–
7.
23. Treutlein J, Cichon S, Ridinger M, Wodarz N, Soyka M, Zill P, et al. Genome-wide association study of
alcohol dependence. Archives of general psychiatry. 2009; 66(7):773–84. doi: 10.1001/
archgenpsychiatry.2009.83 PMID: 19581569
24. Heath AC, Whitfield JB, Martin NG, Pergadia ML, Goate AM, Lind PA, et al. A quantitative-trait
genome-wide association study of alcoholism risk in the community: findings and implications. Biologi-
cal psychiatry. 2011; 70(6):513–8. doi: 10.1016/j.biopsych.2011.02.028 PMID: 21529783
25. Park BL, Kim JW, Cheong HS, Kim LH, Lee BC, Seo CH, et al. Extended genetic effects of ADH cluster
genes on the risk of alcohol dependence: from GWAS to replication. Human genetics. 2013; 132
(6):657–68. doi: 10.1007/s00439-013-1281-8 PMID: 23456092
26. Dick DM, Foroud T. Candidate genes for alcohol dependence: a review of genetic evidence from
human studies. Alcoholism: Clinical and Experimental Research. 2003; 27(5):868–79.
27. Treutlein J, Rietschel M. Genome-wide association studies of alcohol dependence and substance use
disorders. Current psychiatry reports. 2011; 13(2):147–55. doi: 10.1007/s11920-011-0176-4 PMID:
21253885
Alcohol Consumption Polygenic Risk Score
PLOS ONE | DOI:10.1371/journal.pone.0167360 November 30, 2016 13 / 15
28. Birley AJ, James MR, Dickson PA, Montgomery GW, Heath AC, Martin NG, et al. ADH single nucleotide
polymorphism associations with alcohol metabolism in vivo. Human molecular genetics. 2009; 18
(8):1533–42. doi: 10.1093/hmg/ddp060 PMID: 19193628
29. Golding J, Pembrey M, Jones R, Team AS. ALSPAC—the Avon Longitudinal Study of Parents and Chil-
dren. I. Study methodology. Paediatr Perinat Epidemiol. 2001; 15(1):74–87. PMID: 11237119
30. Boyd A, Golding J, Macleod J, Lawlor DA, Fraser A, Henderson J, et al. Cohort Profile: the ’children of
the 90s’—the index offspring of the Avon Longitudinal Study of Parents and Children. International jour-
nal of epidemiology. 2013; 42(1):111–27. PubMed Central PMCID: PMC3600618. doi: 10.1093/ije/
dys064 PMID: 22507743
31. Fraser A, Macdonald-Wallis C, Tilling K, Boyd A, Golding J, Davey Smith G, et al. Cohort Profile: the
Avon Longitudinal Study of Parents and Children: ALSPAC mothers cohort. International journal of epi-
demiology. 2013; 42(1):97–110. PubMed Central PMCID: PMC3600619. doi: 10.1093/ije/dys066
PMID: 22507742
32. ALSPAC. Data Dictionary http://www.bris.ac.uk/alspac/researchers/data-access/data-dictionary/;
archived at http://www.webcitation.org/6Tgld7Ze02014.
33. Welter D, MacArthur J, Morales J, Burdett T, Hall P, Junkins H, et al. The NHGRI GWAS Catalog, a
curated resource of SNP-trait associations. Nucleic acids research. 2014; 42(D1):D1001–D6.
34. StataCorp. Stata Statistical Software: Release 13. 2013.
35. Palla L, Dudbridge F. A fast method that uses polygenic scores to estimate the variance explained by
genome-wide marker panels and the proportion of variants affecting a trait. The American Journal of
Human Genetics. 2015; 97(2):250–9. doi: 10.1016/j.ajhg.2015.06.005 PMID: 26189816
36. BHF. Cardiovascular disease statistics 2015: British Heart Foundation; 2015 [09 June 2016]. Available
from: https://www.bhf.org.uk/research/heart-statistics/heart-statistics-publications/cardiovascular-
disease-statistics-2015.
37. Ronksley PE, Brien SE, Turner BJ, Mukamal KJ, Ghali WA. Association of alcohol consumption with
selected cardiovascular disease outcomes: a systematic review and meta-analysis. Bmj. 2011; 342:
d671. doi: 10.1136/bmj.d671 PMID: 21343207
38. Brion M-JA, Shakhbazov K, Visscher PM. Calculating statistical power in Mendelian randomization
studies. International journal of epidemiology. 2013; 42(5):1497–501. doi: 10.1093/ije/dyt179 PMID:
24159078
39. Heron J, Macleod J, Munafo MR, Melotti R, Lewis G, Tilling K, et al. Patterns of alcohol use in early ado-
lescence predict problem use at age 16. Alcohol and alcoholism. 2012; 47(2):169–77. PubMed Central
PMCID: PMC3284685. doi: 10.1093/alcalc/agr156 PMID: 22215001
40. Melotti R, Heron J, Hickman M, Macleod J, Araya R, Lewis G, et al. Adolescent alcohol and tobacco use
and early socioeconomic position: the ALSPAC birth cohort. Pediatrics. 2011; 127(4):e948–55. Epub
2011/03/16. doi: 10.1542/peds.2009-3450 PMID: 21402626
41. MacArthur GJ, Smith MC, Melotti R, Heron J, Macleod J, Hickman M, et al. Patterns of alcohol use and
multiple risk behaviour by gender during early and late adolescence: the ALSPAC cohort. Journal of
public health (Oxford, England). 2012; 34 Suppl 1:i20–30. PubMed Central PMCID: PMC3284864.
42. Lees R, Kingston R, Williams T, Henderson G, Lingford-Hughes A, Hickman M. Comparison of Ethyl
Glucuronide in Hair with Self-Reported Alcohol Consumption. Alcohol and alcoholism. 2012; 47
(3):267–72. doi: 10.1093/alcalc/ags010 PMID: 22336766
43. Peterson K. Biomarkers for alcohol use and abuse-a summary. Alcohol Research and Health. 2004; 28
(1):30. PMID: 19006989
44. Achur RN, Freeman WM, Vrana KE. Circulating cytokines as biomarkers of alcohol abuse and alcohol-
ism. Journal of Neuroimmune Pharmacology. 2010; 5(1):83–91. doi: 10.1007/s11481-009-9185-z
PMID: 20020329
45. Midanik L. The validity of self-reported alcohol consumption and alcohol problems: A literature review.
British journal of addiction. 1982; 77(4):357–82. PMID: 6762224
46. Stockwell T, Donath S, Cooper-Stanbury M, Chikritzhs T, Catalano P, Mateo C. Under-reporting of alco-
hol consumption in household surveys: a comparison of quantity–frequency, graduated–frequency and
recent recall. Addiction. 2004; 99(8):1024–33. doi: 10.1111/j.1360-0443.2004.00815.x PMID:
15265099
47. Edwards AL. The social desirability variable in personality assessment and research1957.
48. Dudbridge F. Power and predictive accuracy of polygenic risk scores. PLoS genetics. 2013; 9(3):
e1003348. doi: 10.1371/journal.pgen.1003348 PMID: 23555274
49. Burgess S, Butterworth AS, Thompson JR. Beyond Mendelian randomization: how to interpret evidence
of shared genetic predictors. Journal of clinical epidemiology. 2016; 69:208–16. doi: 10.1016/j.jclinepi.
2015.08.001 PMID: 26291580
Alcohol Consumption Polygenic Risk Score
PLOS ONE | DOI:10.1371/journal.pone.0167360 November 30, 2016 14 / 15
50. Clarke T, Hall L, Fernandez-Pujals A, MacIntyre D, Thomson P, Hayward C, et al. Major depressive dis-
order and current psychological distress moderate the effect of polygenic risk for obesity on body mass
index. Translational psychiatry. 2015; 5(6):e592.
51. Hung C-F, Breen G, Czamara D, Corre T, Wolf C, Kloiber S, et al. A genetic risk score combining 32
SNPs is associated with body mass index and improves obesity prediction in people with major depres-
sive disorder. BMC medicine. 2015; 13(1):1.
52. Walter S, Kubzansky LD, Koenen KC, Liang L, Tchetgen Tchetgen EJ, Cornelis MC, et al. Revisiting
mendelian randomization studies of the effect of body mass index on depression. American Journal of
Medical Genetics Part B: Neuropsychiatric Genetics. 2015; 168(2):108–15.
53. Shen L, Walter S, Melles RB, Glymour MM, Jorgenson E. Diabetes Pathology and Risk of Primary
Open-Angle Glaucoma: Evaluating Causal Mechanisms by Using Genetic Information. American jour-
nal of epidemiology. 2016; 183(2):147–55. doi: 10.1093/aje/kwv204 PMID: 26608880
54. Taylor AE, Burgess S, Ware JJ, Gage SH, Richards JB, Smith GD, et al. Investigating causality in the
association between 25 (OH) D and schizophrenia. Scientific reports. 2016; 6:26496. doi: 10.1038/
srep26496 PMID: 27215954
55. Chou Y, Madden P, Bierut L, Heath A, Bucholz K, Agrawal A. Genome-wide polygenic scores for age at
onset of alcohol dependence and association with alcohol-related measures. Translational Psychiatry.
2016; 22:e761.
56. Vink JM, Hottenga JJ, de Geus EJ, Willemsen G, Neale MC, Furberg H, et al. Polygenic risk scores for
smoking: predictors for alcohol and cannabis use? Addiction. 2014; 109(7):1141–51. PubMed Central
PMCID: PMC4048635. doi: 10.1111/add.12491 PMID: 24450588
Alcohol Consumption Polygenic Risk Score
PLOS ONE | DOI:10.1371/journal.pone.0167360 November 30, 2016 15 / 15
